RadNet, Inc. (NASDAQ:RDNT)
| Market Cap | $5.99B+3.5% |
| Revenue (ttm) | $2.38B+21.1% |
| Net Income | -$22.38M-76.1% |
| EPS | -$0.29-60.6% |
| Shares Out | 78.77M |
| PE Ratio | n/a |
| Forward PE | 87.37 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 407,927 |
| Open | $78.09 |
| Previous Close | $78.08 |
| Day's Range | $75.91 - $78.24 |
| 52-Week Range | $50.82 - $85.84 |
| Beta | 1.40 |
| Analysts | Buy |
| Price Target | $80.00(+5.21%) |
| Earnings Date | Mar 1, 2027 |
About RDNT
RadNet, Inc. operates as a prominent healthcare services company specializing in outpatient diagnostic imaging across the United States. Their comprehensive offerings span a broad spectrum of advanced imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, and general diagnostic radiology, along with various specialized procedures. Beyond direct patient services, the company also plays a significant role in developing and marketing specialized computerized systems for the diagnostic imaging sector, such as picture archiving communication systems (PACS) and associated support. Furthermore, RadNet is at the forefront of integrating artificial intelligence (AI) solutions, designing and deploying AI suites to augment radiologist interpretation, particularly in mammography, and extending these AI capabilities to lung and prostate cancer diagnostics. As of December 31, 2021, its operational footprint included ownership and management of 347 centers situated across seven states: Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Established in 1981, the company maintains its headquarters in Los Angeles, California.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
Analyst consensus
2 firms rating RDNT in the last 3 months, one vote each. Issuer-paid research is not counted.
Next catalysts
- Mar 1, 2027Earnings report
$RDNT stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in RDNT holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by RDNT's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
RDNT Estimated quarterly lobbying spending
Source: U.S. Senate LDA
RDNT Revenue by Segment or Geography
| Commercial insurance | $343.33M | 56.56% |
| Medicare | $158.13M | 26.05% |
| Other payors | $37.56M | 6.19% |
| Other revenue | $32.42M | 5.34% |
| Medicaid | $14.76M | 2.43% |
| Workers' compensation/personal injury | $13.24M | 2.18% |
| Management fee revenue | $7.57M | 1.25% |
As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New RDNT patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to RDNT from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in RDNT
| IJRiShares Core S&P Small-Cap ETF | $274.36M |
| VTIVanguard Morningstar Total Stock Market ETF | $156.18M |
| IWMiShares Russell 2000 ETF | $144.45M |
| VBVanguard Morningstar Small-Cap ETF | $109.82M |
| QTUMDefiance Quantum ETF | $83.58M |
| VBKVanguard Morningstar Small-Cap Growth ETF | $61.21M |
Estimated from each fund’s disclosed top holdings × AUM
Bull Case vs Bear Case
AI-generated from RDNT’s recent data — informational, not investment advice
What’s Behind the Score
News check: RadNet announced collaboration with WIN-NextGen on medical imaging careers, a modest positive development showing industry engagement, though lacking major business catalysts.
Recent Insider Activity
Frequently Asked Questions
ETFs that hold this stock
| RSMC | Rockefeller U.S. Small-Mid Cap ETF | 3.52% |
| PSCH | Invesco S&P SmallCap Health Care ETF | 2.91% |
| SMCO | Hilton Small-MidCap Opportunity ETF | 2.20% |
| FFOX | FundX Future Fund Opportunities ETF | 1.78% |
| XHS | State Street SPDR S&P Health Care Services ETF | 1.77% |
| QTUM | Defiance Quantum ETF | 1.73% |
| NSCS | Nuveen Small Cap Select | 1.06% |
| LFSC | F/M Emerald Life Sciences Innovation ETF | 0.94% |
| JSML | Janus Henderson Small Cap Growth Alpha ETF | 0.90% |
| MEDI | Harbor Health Care ETF (MEDI) | 0.88% |
| ACSG | American Century Small Cap Growth Insights ETF | 0.83% |
| FNY | First Trust Mid Cap Growth AlphaDEX Fund | 0.66% |
Weight is the stock’s share of each fund’s holdings.